Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
Clinical trial NCT01207427 · COMPLETED
Trial details
- NCT number
- NCT01207427
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-14
- Primary completion
- 2011-04-18
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.